Vesilute is a Khavinson bioregulator peptide with research exploring its role in regulating the urinary tract and prostate gland.

Research evidence indicates that Vesilute may help to relieve symptoms associated with bladder and urinary tract

dysfunction. Vesilute and other cytomedines have been shown to reduce prostate dysfunction and are thought to act by

improving microcirculation in the prostate and by reducing cell proliferation. The latter effect may be due to changes in

chromosome density and epigenetic factors, a mechanism of cellular regulation that is common among Khavinson peptides.